Abstract
Nanotechnology has emerged as a transformative field in medicine, enabling the design of nanoscale systems for diagnostics, imaging, and therapy. Among these, gold nanoparticles (AuNPs) have attracted significant attention owing to their tunable size (1–100 nm), inert nature, ease of synthesis, and unique optical properties that have been recognized since their use in ancient artwork. In recent years, AuNPs have demonstrated broad biomedical applications, including photothermal therapy, targeted drug delivery, antiviral strategies, early detection of cardiovascular disorders, cancer diagnosis, kidney disease monitoring, bioimaging, and biosensing. Their surfaces can be functionalized with peptides, antibodies, or polymers to achieve selective cellular targeting through mechanisms such as the enhanced permeability and retention (EPR) effect and receptor-mediated endocytosis. They can be used for other applications with different properties as well by changing the size and chemistry of the gold nanoparticles. The working of gold nanoparticles is first checked in vitro and then in vivo using animal models. Despite these advantages, challenges remain, including dose-dependent cytotoxicity, stability concerns, and regulatory barriers that limit large-scale clinical translation. Continued research focusing on surface modification, synthesis, and immune evasion strategies is expected to further expand the therapeutic and diagnostic potential of gold nanoparticles.
References
1. Alaqad K, Saleh TA. Gold and silver nanoparticles: synthesis methods, characterization routes and applications towards drugs. Environ Anal Toxicol. 2016;6(4):384.
2. Roy A. Plant derived silver nanoparticles and their therapeutic applications. Current Pharmaceutical Biotechnology. 2021;22(14):1834-47.
3. dos Santos Haupenthal DP, Mendes C, de Bem Silveira G, Zaccaron RP, Corrêa ME, Nesi RT, Pinho RA, da Silva Paula MM, Silveira PC. Effects of treatment with gold nanoparticles in a model of acute pulmonary inflammation induced by lipopolysaccharide. Journal of Biomedical Materials Research Part A. 2020;108(1):103-15.
4. Baranes K, Shevach M, Shefi O, Dvir T. Gold nanoparticle-decorated scaffolds promote neuronal differentiation and maturation. Nano letters. 2016;16(5):2916-20.
5. Wan D, Chen D, Li K, Qu Y, Sun K, Tao K, Dai K, Ai S. Gold nanoparticles as a potential cellular probe for tracking of stem cells in bone regeneration using dual-energy computed tomography. ACS Applied Materials & Interfaces. 2016;8(47):32241-9.
6. Shagan A, [Institutional report]. New method uses light and gold nanoparticles for highly targeted, non-invasive drug delivery. Technion-Israel Institute of Technology. 2018.
7. Hammami I, Alabdallah NM. Gold nanoparticles: Synthesis properties and applications. J King Saud Univ Sci. 2021;33(7):101560.
8. Tiwari PM, Bawage SS, Singh SR. Gold nanoparticles and their applications in photomedicine, diagnosis and therapy. Nanotechnol Rev. 2015;4(3):249-66.
9. Xu L, Xu M, Sun X, Feliu N, Feng L, Parak WJ, Liu S. Quantitative comparison of gold nanoparticle delivery via the enhanced permeation and retention (EPR) effect and mesenchymal stem cell (MSC)-based targeting. ACS Nano. 2023;17(3):2039-52.
10. Hong L, Li W, Li Y, Yin S. Nanoparticle-based drug delivery systems targeting cancer cell surfaces. RSC Adv. 2023;13(31):21365-82.
11. Becker KH, Zhu W. Gold nanoparticles show promise for early detection of heart attacks. New York University. 2015.Rowles D. Why gold nanoparticles offer a bright future for diagnostics and healthcare. 2018. [Online Report].
12. Bavelaar B. Gold nanoparticles can deliver drugs into heart of cancer cells. Oxford University. 2016.
13. Zheng J. Gold nanoparticles may help improve understanding, detection of kidney disease. University of Texas at Dallas. 2016.
14. Luo D, Wang X, Burda C, Basilion JP. Recent development of gold nanoparticles as contrast agents for cancer diagnosis. Cancers. 2021;13(8):1825.
15. Kesharwani P, Ma R, Sang L, Fatima M, Sheikh A, Abourehab MA, Gupta N, Chen ZS, Zhou Y. Gold nanoparticles and gold nanorods in the landscape of cancer therapy. Mol Cancer. 2023;22(1):98.
16. Shittu KO, Bankole MT, Abdulkareem AS, Abubakre OK, Ubaka AU. Application of gold nanoparticles for improved drug efficiency. Adv Nat Sci Nanosci Nanotechnol. 2017;8(3):035014.
17. Marc C. Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism. Nat Mater. 2017;16(5):719-25.
18. Malki M, Fleischer S, Shapira A, Dvir T. Gold nanorod-based engineered cardiac patch for suture-free engraftment by near IR. Nano Lett. 2018;18(7):4064-73.
19. Ramachandran R, Krishnaraj C, Kumar VA, Harper SL, Kalaichelvan TP, Yun SI. In vivo toxicity evaluation of biologically synthesized silver nanoparticles and gold nanoparticles on adult zebrafish: a comparative study. 3 Biotech. 2018;8(10):441.
20. Niżnik Ł, Noga M, Kobylarz D, Frydrych A, Krośniak A, Kapka-Skrzypczak L, Jurowski K. Gold nanoparticles (AuNPs)—toxicity, safety and green synthesis: a critical review. Int J Mol Sci. 2024;25(7):4057.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Pak-Euro Journal of Medical and Life Sciences